Skip to main content
. 2018 Apr 18;2018(4):CD006545. doi: 10.1002/14651858.CD006545.pub3

Comparison 15. Oral propranolol versus intralesional propranolol.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Clearance 1 30 Risk Ratio (M‐H, Random, 95% CI) 4.5 [1.16, 17.44]
2 Adverse events: syncopal attack 1 30 Risk Ratio (M‐H, Random, 95% CI) 7.0 [0.39, 124.83]